Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results

Last Modified: 7/24/2007 First Published: 6/8/2007


1.		Phase I/II Study of Hydroxychloroquine, Radiotherapy, and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				NABTT-0603 NABTT-0603, 0603, NCT00486603

Last Modified: 5/22/2008 First Published: 12/4/2007


2.		Phase I/II Study of Hydroxychloroquine and Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				UPCC-01407 UPCC 01407, UPCC-IRB-806149, NCT00568880

Last Modified: 8/29/2008 First Published: 7/24/2008


3.		Phase I/II Study of Hydroxychloroquine in Combination With Carboplatin, Paclitaxel, and Bevacizumab in Patients With Recurrent Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				CINJ-030801 030801, NCT00728845

First Published: 7/30/2008


4.		Phase II Study of Hydroxychloroquine in Patients With Hormone-Dependent Prostate-Specific Antigen (PSA) Progression After Local Therapy for Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				CINJ-080803 080803, NCT00726596

First Published: 7/10/2008


5.		Phase I Study of Hydroxychloroquine and Temozolomide in Patients With Metastatic or Unresectable Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Active				18 and over				NCI				UPCC-12907 UPCC 12907, NCT00714181

Select All on One Page